Results 21 to 30 of about 211,077 (381)

Prevention and Management of Cerebral Small Vessel Disease [PDF]

open access: yesJournal of Stroke, 2015
Lacunar infarcts/lacunes, white matter hyperintensities (WMH), and cerebral microbleeds (CMBs) are considered various manifestations of cerebral small vessel disease (SVD).
Vincent Mok, Jong S. Kim
doaj   +3 more sources

Current pathophysiological concepts in Cerebral Small Vessel Disease [PDF]

open access: yesFrontiers in Aging Neuroscience, 2014
The association between cerebral small vessel disease (SVD) – in the form of white matter lesions, infarctions, and hemorrhages – with vascular cognitive impairment (VCI), has mostly been deduced from observational studies.
Fred eRincon, Clinton eWright
doaj   +4 more sources

Estrogen and cerebral small vessel disease

open access: yesChinese Medical Journal, 2021
Hui Gao   +4 more
doaj   +4 more sources

Pathophysiology and probable etiology of cerebral small vessel disease in vascular dementia and Alzheimer’s disease

open access: yesMolecular Neurodegeneration, 2023
Vascular cognitive impairment and dementia (VCID) is commonly caused by vascular injuries in cerebral large and small vessels and is a key driver of age-related cognitive decline.
Yasuteru Inoue   +3 more
semanticscholar   +1 more source

Cerebral Small Vessel Disease, Hypertension, and Vascular Contributions to Cognitive Impairment and Dementia

open access: yesHYPERTENSION, 2023
Hypertension-associated cerebral small vessel disease is a common finding in older people. Strongly associated with age and hypertension, small vessel disease is found at autopsy in over 50% of people aged ≥65 years, with a spectrum of clinical ...
A. Hainsworth   +2 more
semanticscholar   +1 more source

Isosorbide Mononitrate and Cilostazol Treatment in Patients With Symptomatic Cerebral Small Vessel Disease

open access: yesJAMA Neurology, 2023
Key Points Question Can modulators of cerebrovascular endothelial function, including isosorbide mononitrate (ISMN; a nitric oxide donor) and cilostazol (a phosphodiesterase-3 inhibitor), improve long-term outcomes after lacunar ischemic stroke? Findings
J. Wardlaw   +15 more
semanticscholar   +1 more source

Cerebral small vessel disease: A glymphopathy? [PDF]

open access: yesCurrent Opinion in Neurobiology, 2022
Small vessel disease (SVD) is a common instigator of dementia in the aging population. The hallmarks of SVD are enlargement of the perivascular spaces and white matter hyperintensities. The latter represents local fluid accumulation in white matter that either subsides or develops into lacunar infarcts.
Benveniste, Helene, Nedergaard, Maiken
openaire   +3 more sources

Gait and falls in cerebral small vessel disease: a systematic review and meta-analysis

open access: yesAge and Ageing, 2023
Background Gait impairment contributes to falls and frailty. Some studies suggest that cerebral small vessel disease (CSVD) is associated with gait impairment in the general population.
Breni Sharma   +4 more
semanticscholar   +1 more source

White matter changes and gait decline in cerebral small vessel disease [PDF]

open access: gold, 2017
The relation between progression of cerebral small vessel disease (SVD) and gait decline is uncertain, and diffusion tensor imaging (DTI) studies on gait decline are lacking.
Helena M. van der Holst   +13 more
openalex   +6 more sources

Research progress of impaired cerebral hemodynamics in cerebral small vessel disease

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2021
Cerebral hemodynamic damage is an important mechanism in the pathogenesis of arteriolosclerotic cerebral small vessel disease (CSVD). The hemodynamic damage of cerebral small vessel disease includes the changes of blood pressure variability (BPV ...
LIU Na   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy